Navigation Links
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
Date:5/14/2008

ndidate vaccine)" Presented at:

SGO's Annual Meeting on Women's Cancer. March 10, 2008 Tampa

Convention Center.

(13) Gravitt PE, Jamshidi R. Diagnosis and management of oncogenic

cervical human papillomavirus infection. Infect Dis Clin North Am,

2005; 19:439-458

(14) Munoz N, Bosch FX, de Sanjose S,et al. Epidemiologic classification

of human papillomavirus types associated with cervical cancer. N Engl

J Med 2003; 348: 518-527

(15) Munoz N, Bosch FX, Castellsague X et al. Against which human

papillomavirus types shall we vaccinate and screen? The international

perspective. Int. J. Cancer 2004; 111; 278-285

(16) Baseman JG, Koutsky LA. The epidemiology of human papillomavirus

infections J Clin Virol 2005; 32 Suppl 1; S16-24

(17) World Health Organization. Initiative for Vaccine Research.

http://www.who.int/vaccine_research/diseases/hpv/en/ Accessed on May

2, 2007


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. RediClinic Offers Affordable New Plan Clinically Shown to Double a Persons Chance to Stop Smoking
2. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
3. Divine Corporations Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
4. Evotecs EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks
5. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
6. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
7. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
8. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
9. Raptor Pharmaceuticals Provides Update of Product Programs
10. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
11. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2008)...INGAPORE, Aug. 15 /- AstraZ...new partnership with the National Cancer,Centre Si...l (NUH) to,develop anti-cancer compounds. The coll...nderstanding (MOU) that was signed today, aims to ...ilities in Asia and ultimately,speed up access to ...
(Date:8/14/2008)...st T cell engaging antibody (BiTE) showing clinica... patients own T cells to recognize and attack ...Md., Aug. 14 /- Micromet, I...developing novel, proprietary,antibodies for the t...seases, today announced publication of a Phase 1 c...
(Date:8/14/2008)... - Phase 2 development to begin in late 2008 or i...wswire-FirstCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO )...b,proof-of-concept trial of NU172, demonstrating t... and maintained anticoagulation with a rapid,retur...favorable safety,profile., "NU172 has the potenti...
(Date:8/13/2008)...igh Omega-3 Fat Intake Improves Insulin Sensitivit...lter Endocrine Responsiveness, PHOENIX, Aug. 13 /...enix-based Kronos Longevity Research Institute (KL... insulin sensitivity and reduces inflammatory,mark...This study was,recently published in Hormones and ...
Breaking Medicine Technology:AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Study Shows Benefits of a High Omega-3 Diet in Older Adults 2Study Shows Benefits of a High Omega-3 Diet in Older Adults 3Biophysical Society announces winners of 2008 Minority Travel Awards 1714 1Biophysical Society announces winners of 2008 Minority Travel Awards 1714 2Kids in Poor Neighborhoods Fall Behind in School 8726 1Kids in Poor Neighborhoods Fall Behind in School 8726 2Songbirds offer clues to highly practiced motor skills in humans 8724 1Songbirds offer clues to highly practiced motor skills in humans 8724 2Songbirds offer clues to highly practiced motor skills in humans 8724 3Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America 8720 1Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America 8720 2
.../ -- A new Harris Poll,suggests that the flu vacci...ctive than the vaccines used in some previous year... were only 24 percent,less likely to get the flu t... were larger in two previous Harris Polls on the s.../2005 adults who were,vaccinated were 33 percent a...
...udy showed significant,results in favor of alemtuz...., May 02, 2007,/PRNewswire-FirstCall/ -- Genzyme ...day announced detailed interim results from the,CA... patient data,through at least twenty-four months ...d that a once-yearly cycle of alemtuzumab,treatmen...
Other Medicine Technology:Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 2Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 3Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 4Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 5Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than,Vaccines Used in Previous Years 6Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 2Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 3Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 4Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 5Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 6Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 7Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 8Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 9
(Date:8/20/2008)...WTON, Mass., Aug. 20 /PRNewswire/ -- Questex Media...siness media company and owner of,American Spa and... the,International Beauty Shows, the International...d the SPATEC appointment events today announced th... portals SpaTrade (, http://www.SpaTrade.com ) an...
(Date:8/20/2008)...r in secondary life insurance market ranked 156 am...in America on Inc. 500 list, BETHESDA, Md., Aug. ...der in the secondary life insurance market, announ...growing insurance related company in the US by,Inc... 2008 Inc. 500 list of,fastest growing companies i...
(Date:8/20/2008)...UTHFIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/... Wellness Promotion will give thousands of,Detroit..."HEALTHY LIVING,FOR KIDS" program. This year the p...0 a.m. to 5 p.m. at the Charles H. Wright Museum o... 1977, "Healthy Living for Kids",has provided free...
(Date:8/20/2008)...LWAUKEE, Aug. 20 /PRNewswire/ -- Fourteen physicia...p have announced that they plan to enhance,the car...ining Aurora,Health Care., "These are top-notch p...have decided to join our organization," said Nick ...ve officer. "We look forward to working with,them ...
Breaking Medicine News(10 mins):Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc. Magazine 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3Health News:Commonwealth Medical Group Physicians to Join Aurora Health Care 2
...ucted by drug researchers has revealed that enabli...ates who are addicted to heroin, //would serve a d...nce and the cost of locking up prisoners for a yea...l Health and Medical Research Council sponsored th...
...ugh a study by neuroscientists at Harvard Medical ...-term exposure to stress hormone in mice directly ...ssion. // April issue of Behavioral Neuroscience, ...chological Association, has this article. This wo...
...es on headline-grabbing diseases, hemophilia, a li...silent killer with over 50,000 people affected. //... to promote a global effort to secure appropriate ...is the oldest known inherited bleeding disorder ca...
...e the promising field of stem cell technology furt...g study //that intends to verify the virtue, succe... a cure for heart disease. Experiments will be c... heart patients. This study will be a fusion of ef...
Other Medicine News:Health News:Cost-Benefit Economics of Methadone for prisoners 2
Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles.
Heine Beta 200 Streak Retinoscope 3.5v
Video Equipment
Micro-mini fiber optic light.
Medicine Products: